Rheumatoid arthritis: vizsgálatok itt: Brazília
11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év to 65 év
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - 1/2. fázisTaking peopleA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Where
- Aparecida de Goiânia, Porto Alegre, Valinhos
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Where
- Brasília, Cuiab, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, So Paulo
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07137598 - 2. fázisTaking peopleAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Where
- Juiz de Fora
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Where
- Juiz de Fora, Pelotas, Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07276581 - No phaseTaking peopleTwenty-four Hour Movement Behaviors and Atherosclerotic Risk
- Where
- Presidente Prudente
- Életkor
- 18 év to 65 év
- People
- 150
- Run by
- São Paulo State University
See details and how to joinNCT07774507 - 2. fázisTaking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Brasília, Cuiabá, Porto Alegre, Rio Grande, São Paulo
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - 4. fázisTaking peopleSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Where
- São Paulo
- Életkor
- 12 év to 59 év
- People
- 477
- Run by
- University of Sao Paulo General Hospital
See details and how to joinNCT07087912 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Campinas, São Paulo
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - No phaseCsak meghívásosEffect of Home-Based Transcranial Direct Current Stimulation on Pain in Patients With Rheumatoid Arthritis With Low Inflammatory Activity
- Where
- Porto Alegre
- Életkor
- 18 év to 70 év
- People
- 34
- Run by
- Federal University of Rio Grande do Sul
See details and how to joinNCT07162311